BE627717A - - Google Patents
Info
- Publication number
- BE627717A BE627717A BE627717DA BE627717A BE 627717 A BE627717 A BE 627717A BE 627717D A BE627717D A BE 627717DA BE 627717 A BE627717 A BE 627717A
- Authority
- BE
- Belgium
- Prior art keywords
- aqueous solution
- anion
- molar
- solution according
- desc
- Prior art date
Links
- 239000007864 aqueous solution Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- 150000001450 anions Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 6
- RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 150000007524 organic acids Chemical class 0.000 claims 2
- 150000002894 organic compounds Chemical class 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- 206010006451 bronchitis Diseases 0.000 description 6
- 230000003071 parasitic effect Effects 0.000 description 5
- 241000282817 Bovidae Species 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 229960003974 diethylcarbamazine Drugs 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- 206010024769 Local reaction Diseases 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000010006 flight Effects 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000008237 rinsing water Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE627717A true BE627717A (enrdf_load_stackoverflow) |
Family
ID=197928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE627717D BE627717A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE627717A (enrdf_load_stackoverflow) |
-
0
- BE BE627717D patent/BE627717A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH630260A5 (fr) | Compositions antibiotiques a base d'une tetracycline. | |
| CA2231342C (fr) | Composition pharmaceutique pour administration par voie orale | |
| SK12993A3 (en) | Pharmaceutical composition of florfenicol | |
| RU2015131700A (ru) | Фармацевтические композиции, включающие производное камптотецина | |
| KR20200052934A (ko) | 경피 제제 | |
| US6248731B1 (en) | Stabilized aspirin compositions and method of preparation for oral & topical use | |
| CH644015A5 (fr) | Solution aqueuse injectable a base d'oxytetracycline. | |
| BE627717A (enrdf_load_stackoverflow) | ||
| JPS6218526B2 (enrdf_load_stackoverflow) | ||
| BG64299B1 (bg) | Полутвърда фармацевтична форма, съдържаща декскетопрофен трометамол | |
| EP0575481B1 (fr) | Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4 | |
| RU2372904C2 (ru) | Композиция альфа-липоевой (тиоктовой) кислоты, способ ее получения и способ лечения | |
| EP0271374B1 (fr) | Composition antibiotique aqueuse à usage vétérinaire | |
| FI100695B (fi) | Menetelmä valmistaa salisyylihappopitoinen aine hilseileviä ihosairauk sia vastaan | |
| RU2396081C1 (ru) | Фармацевтическая композиция для лечения дерматозов, поддающихся глюкокортикостероидной терапии, и способ ее получения | |
| FR2544198A1 (fr) | Compositions pharmaceutiques topiques a base d'acide meclophenamique | |
| RU2488402C1 (ru) | Средство, обладающее противовоспалительным и противоаллергическим действием | |
| USRE38576E1 (en) | Stabilized aspirin compositions and method of preparation for oral and topical use | |
| FR2739778A1 (fr) | Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal | |
| JP2829261B2 (ja) | 家畜のビタミンｅ・セレン欠乏症に適用する注射剤 | |
| USRE38443E1 (en) | Stabilized aspirin compositions and method of preparation of oral and topical use | |
| JPH0597680A (ja) | グリチルリチン坐剤 | |
| RU2278661C2 (ru) | Противопаразитарное средство | |
| CH653258A5 (fr) | Melange de cromoglycate de sodium et de xylometazoline et procede pour le preparer. | |
| CH422787A (fr) | Procédé de préparation d'un sel complexe d'éthionamide en solution |